Back to 
Renaissance Technologies LLC
Renaissance Technologies LLC
BCLI
Showing 0 of 16 quarters
Position history for Renaissance Technologies LLC's holdings in BRAINSTORM CELL THERAPEUTICS
No. Renaissance Technologies exited its BCLI (Brainstorm Cell Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 203,600 shares worth $41,000. Renaissance Technologies already held BCLI in its Q3 2019 13F, the earliest on record, and held it in 11 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of BCLI: State Street Corp., Geode Capital Management, LLC, Invesco Ltd., Northern Trust Corp.